静脉血栓栓塞后女性抗凝相关异常月经出血的发生率及影响
TEAM-VTE 为国际多中心前瞻性队列研究,纳入 98 例 18 至 50 岁急性静脉血栓栓塞女性,用图示失血量评估表及月经出血问卷随访。随访期间 65 例(66%,95%CI 57%-75%)符合至少一种异常子宫出血定义;静脉血栓栓塞诊断前无异常子宫出血者中新发异常子宫出血为 60%(36/60,95%CI 47%-71%);总体生活质量下降,月经出血问卷评分平均升高 5.1 分(95%CI 2.2-7.9),且仅见于新发异常子宫出血者。
要点
- 急性静脉血栓栓塞女性抗凝后,每 3 人中约 2 人出现异常子宫出血(66%,95%CI 57%-75%)。
- 静脉血栓栓塞前无异常子宫出血者中新发异常子宫出血为 60%(36/60,95%CI 47%-71%)。
- 月经出血问卷评分平均升高 5.1 分(95%CI 2.2-7.9),生活质量下降仅见于新发异常子宫出血者。
核心结论
- 每 3 名因急性静脉血栓栓塞开始抗凝的女性中约 2 名出现异常子宫出血,并对生活质量造成相当大的负面影响。
- 作者认为这些发现应成为行动呼吁,以提高认识并提供循证策略来预防和治疗此情景下的异常子宫出血。
研究设计与样本
- TEAM-VTE 为国际多中心前瞻性队列研究,纳入 98 例 18 至 50 岁诊断为急性静脉血栓栓塞的女性。
- 月经失血量通过图示失血量评估表测量,基线评估静脉血栓栓塞诊断前最后一个周期,随访 3 至 6 个月期间每个周期前瞻性评估。
- 异常子宫出血定义为图示失血量评估表评分升高(>100 或 >150)或自我报告的异常子宫出血。
- 生活质量在基线和随访结束时使用月经出血问卷评估。
- 研究因 COVID-19 大流行导致招募缓慢而提前终止;该学术研究注册于 www.clinicaltrials.gov 编号 NCT04748393,未获得资金。
主要发现
- 98 例女性中 65 例(66%)在随访期间符合 3 种异常子宫出血定义中的至少一种(95%CI 57%-75%)。
- 静脉血栓栓塞诊断前无异常子宫出血的女性中,异常子宫出血发生率为 60%(36/60,95%CI 47%-71%),即新发异常子宫出血。
- 总体生活质量随时间下降,月经出血问卷评分平均升高 5.1 分(95%CI 2.2-7.9),但该生活质量下降仅见于新发异常子宫出血的女性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究因 COVID-19 大流行导致招募缓慢而提前终止。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Preliminary data and clinical experience have suggested an increased risk of abnormal uterine bleeding (AUB) in women of reproductive age treated with anticoagulants, but solid data are lacking. The TEAM-VTE study was an international multicenter prospective cohort study in women aged 18 to 50 years diagnosed with acute venous thromboembolism (VTE). Menstrual blood loss was measured by pictorial blood loss assessment charts at baseline for the last menstrual cycle before VTE diagnosis and prospectively for each cycle during 3 to 6 months of follow-up. AUB was defined as an increased score on the pictorial blood loss assessment chart (>100 or >150) or self-reported AUB. AUB-related quality of life (QoL) was assessed at baseline and the end of follow-up using the Menstrual Bleeding Questionnaire. The study was terminated early because of slow recruitment attributable to the COVID-19 pandemic. Of the 98 women, 65 (66%) met at least one of the 3 definitions of AUB during follow-up (95% confidence interval [CI], 57%-75%). AUB occurred in 60% of women (36 of 60) without AUB before VTE diagnosis (new-onset AUB; 95% CI, 47%-71%). Overall, QoL decreased over time, with a mean Menstrual Bleeding Questionnaire score increase of 5.1 points (95% CI, 2.2-7.9), but this decrease in QoL was observed only among women with new-onset AUB. To conclude, 2 of every 3 women who start anticoagulation for acute VTE experience AUB, with a considerable negative impact on QoL. These findings should be a call to action to increase awareness and provide evidence-based strategies to prevent and treat AUB in this setting. This was an academic study registered at www.clinicaltrials.gov as #NCT04748393; no funding was received.
引用
- de Jong CMM, Blondon M, Ay C, et al. Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism. Blood. 2022. PMID: 35925686. doi:10.1182/blood.2022017101
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。